University of Tennessee Medical Center
Locations
Transplant Summary
Overview
The Transplant and Cellular Therapy (TCT) Program at The University of Tennessee Medical Center was established in 2021 to provide cutting-edge care for patients with malignant hematologic conditions in East Tennessee. Since initiating allogeneic hematopoietic stem cell transplants (HSCT) in 2022, we have expanded our services to include myeloablative, reduced-intensity, and haploidentical transplant options.
Our adult-only program employs a multidisciplinary approach, ensuring comprehensive and compassionate care tailored to each patient and their families. We are proud to offer in-house clinical trials, providing innovative treatment opportunities and matching patients to trials that best meet their medical needs.
https://www.utmedicalcenter.org/treatments/transplant-and-cellular-therapy-program
Transplant Center Coordinator: Sarah Tyler
Phone: 865-305-9318
Email: Styler@utmck.edu
Financial Representative: Heather Jones
Phone:865-305-9669
Email: hmjones1@utmck.eduThis center has been performing allogeneic transplants since 2023. This center is not a member of the NMDP transplant center network.
Attending physicians
Adult - Kelly McCaul, Renju RajTransplants performed
Marrow/PBSC onlyCord blood transplants
Not performedOther programs and services
In addition to our transplant services, The University of Tennessee Medical Center in Knoxville offers advanced cellular therapies, including CAR-T and Tumor-Infiltrating Lymphocyte (TIL) therapies, providing innovative treatment options for patients with challenging conditions. We are committed to holistic care, offering onsite Integrative Medicine services such as massage therapy, music therapy, and mental health support for both patients and caregivers. Additionally, we connect patients to local support groups, fostering a strong sense of community and support throughout their treatment journey.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 4 patients.The actual 1-year survival of these patients is 50%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 8.8% and 93.7%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
44
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC4Cord blood0Total4Unrelated donorMarrow0PBSC12Cord blood0Total12Total allogeneicMarrow0PBSC16Cord blood0Total16AutologousMarrowBoth marrow & PBSC 28PBSC—Cord blood—Total28Total combinedMarrowBoth marrow & PBSC 44PBSC—Cord blood0Total44All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44045-64365+1Total4Unrelated 0-18019-44345-64265+7Total12Autologous 0-18019-44445-641365+11Total28Total 0-18019-44745-641865+19Total44Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have transplant-related questions, please call the transplant center's direct phone number.
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.